What is an evidence-based protocol for using an Exomind (Transcranial Magnetic Stimulation) TMS machine to treat patients with depression and anxiety?

Evidence-Based TMS Protocols for Depression and Anxiety Using Exomind TMS Machine

Protocol for Major Depressive Disorder (MDD)

For treatment-resistant depression (defined as partial or no response to 2+ adequate pharmacologic trials), use high-frequency left dorsolateral prefrontal cortex (DLPFC) stimulation at 10 Hz, 120% resting motor threshold, 3000 pulses per session, delivered 5 days per week for 4-6 weeks (20-30 total sessions). 1, 2, 3

Treatment Parameters for Depression

• Target location: Left DLPFC 1, 3, 4
• Frequency: 10 Hz (high-frequency stimulation) 1, 3, 4, 5
• Intensity: 120% of resting motor threshold 1, 2, 3, 4, 5
• Pulses per session: 3000 pulses 1, 3, 4, 5
• Session frequency: 5 sessions per week 1, 2, 4, 5
• Total duration: 4-6 weeks (20-30 sessions minimum) 1, 2, 3, 4, 5
• Train parameters: 75 trains with 4 seconds on and 26 seconds off (37.5-minute protocol) 4, 6

Alternative Shortened Protocol

• A 18.75-minute protocol using 75 trains with 4 seconds on and 11 seconds off showed similar remission rates (40% vs 46.7%) and may be equally effective while reducing treatment burden 6

Expected Outcomes for Depression

• Response rates: 29-48% of patients will show significant improvement 1, 2
• Remission rates: Number needed to treat is 5-7 patients for one remission 1, 2
• Duration of response: 3-6 months following acute treatment course 2, 3
• Time to response: Significant improvement typically occurs after 4-6 weeks of daily treatment 2, 3

Maintenance Strategy for Depression

• After acute treatment response, implement maintenance sessions twice weekly for 3 months to extend response duration 2, 3
• Monitor response at 4 weeks, 8 weeks, and end of treatment using standardized depression scales (MADRS, HAMD, or PHQ-9) 1, 6, 5

Critical Caveats for Depression Treatment

• Patient selection: Only highly motivated patients should be selected given the daily treatment burden requiring frequent onsite visits 2, 3
• Insufficient treatment duration: Protocols shorter than 4 weeks show no difference from sham treatment 2, 3
• Placebo effects: One veteran population study with high comorbid PTSD and substance use disorder found no difference between active and sham rTMS, suggesting placebo effects may play an important role in some populations 1, 2
• Adverse events: Side effects are minimal and manageable, primarily transient scalp discomfort or pain, with dropout rates for adverse events around 4.5% 1, 5

---

Protocol for Anxiety Disorders

There is insufficient high-quality evidence to recommend TMS as a primary treatment for anxiety disorders; instead, prioritize manualized evidence-based psychotherapy (particularly cognitive behavioral therapy) as first-line treatment, with pharmacotherapy as an adjunct if needed. 1

Why TMS is Not Recommended for Primary Anxiety Treatment

• Current guidelines from ASCO (2023) recommend psychological and psychosocial interventions from manualized, empirically supported treatments as the primary approach for anxiety in adult populations 1
• No major clinical practice guidelines specifically endorse TMS for generalized anxiety disorder, panic disorder, or social anxiety disorder as a primary indication 1
• The evidence base for TMS in anxiety is substantially weaker than for depression, with most studies focusing on obsessive-compulsive disorder (OCD) rather than generalized anxiety 1

Treatment Approach for Comorbid Depression and Anxiety

When patients present with both depression and anxiety symptoms, treat depressive symptoms as the priority using the depression protocol above, as anxiety symptoms often improve with depression treatment. 1

• Use the standard depression TMS protocol (left DLPFC, 10 Hz, 120% motor threshold, 3000 pulses/session, 5 days/week for 4-6 weeks) 1, 3, 4
• Alternatively, refer for unified protocol combining CBT treatments for both depression and anxiety 1
• Reassess anxiety symptoms at 4 and 8 weeks during depression treatment 1

When to Consider Alternative Approaches for Anxiety

• If anxiety symptoms persist or worsen after 8 weeks of depression-focused TMS treatment despite good adherence, adjust the regimen by adding psychological intervention (individual CBT) or pharmacologic treatment 1
• For treatment-refractory OCD specifically (not generalized anxiety), experimental TMS protocols targeting supplementary motor area are under investigation, but evidence remains insufficient for routine clinical use 1

Monitoring and Adjustment Algorithm

• Week 4 assessment: Use standardized validated instruments to assess symptom relief and treatment satisfaction 1
• Week 8 assessment: If little improvement despite good adherence, add CBT or consider pharmacotherapy 1
• Ongoing: Regularly assess for side effects, adverse events, and barriers to treatment adherence 1

---

Important Safety and Practical Considerations

Contraindications and Precautions

• Screen for seizure history, metallic implants in head/neck, and cardiac pacemakers before initiating treatment 5
• Monitor for treatment-emergent mania/hypomania, particularly in bipolar depression patients 6
• No seizures were reported in the major multisite trial of 301 patients 5

Cognitive Effects During Treatment

• High-frequency stimulation (10-20 Hz) may temporarily disrupt memory, attention, and executive function during active treatment sessions 7
• These cognitive effects are temporary and resolve after treatment 7
• Inform patients about possible transient memory difficulties during the treatment course 7

Access and Resource Requirements

• TMS requires 5 daily visits per week for 4-6 weeks, which represents a significant access barrier 1, 2
• Treatment sessions last 37.5 minutes with standard protocol or 18.75 minutes with shortened protocol 4, 6
• Ensure patients can commit to the full treatment course before initiating, as incomplete courses (less than 4 weeks) are ineffective 2, 3